Comments
Exclusive: GSK nears deal to buy Human Genome - sources
16.07.2012. | NEW YORK/LONDON (Reuters) - GlaxoSmithKline is nearing a deal to acquire Human Genome Sciences for about $2.8 billion in cash after pursuing the U.S. biotech company for three months, two sources familiar with the situation said on Sunday....
